awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36387794-C9E8FAB2-991F-482F-B7E7-D8008F3BB93E
Q36387794-C9E8FAB2-991F-482F-B7E7-D8008F3BB93E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36387794-C9E8FAB2-991F-482F-B7E7-D8008F3BB93E
Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials
P2860
Q36387794-C9E8FAB2-991F-482F-B7E7-D8008F3BB93E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36387794-C9E8FAB2-991F-482F-B7E7-D8008F3BB93E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93d34bc2e80511104bdd202e04ba32dfc1aaac07
P2860
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).